NuShores Biosciences Wins $2.8M Contract

We were unable to send the article.

NuShores Biosciences LLC of Little Rock has won a three-year, $2.8 million contract from the Medical Technology Enterprise Consortium, a nonprofit biomedical technology consortium associated with the U.S. Army Medical Research & Development Command.

The company said the contract will enable it to develop intelligent automated production of its NuCress bone void filler scaffold products using its “factory in a box” concept. 

MiQ Partners of Cincinnati, Ohio, and the University of Arkansas at Little Rock are partners in the project. NuShores is the licensee of UA Little Rock’s bone regeneration products, which have been developed primarily with Department of Defense funding.

The contract work will be led by CEO Sharon Ballard and supported by Manufacturing Manager Mark Pelo. 

“This project will enable NuShores to compete globally in pricing and performance and to accelerate the maturity of emerging products in our pipeline,” Pelo said in a news release.

Ballard said the deal will enable the company to develop “an intelligent, hands-free factory in a box with features such as real-time situational awareness that anticipates failures or production challenges before they cause waste.”

The contract announcement follows the company’s establishment of a medical device clean manufacturing facility, which Arkansas Business reported in August.